首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit
【24h】

Quantitative and qualitative control of cytotoxic preparations by HPLC-UV in a centralized parenteral preparations unit

机译:集中式胃肠外制剂单元中通过HPLC-UV定量和定性控制细胞毒性制剂

获取原文
获取原文并翻译 | 示例
           

摘要

The constantly growing incidence of cancer and long-term treatment are leading to an increasing number of cytotoxic preparations in hospital pharmacies. Security and quality standards of cytotoxic preparations are essential to assure treatment efficiency and limit iatrogenic toxicity. In order to secure the process of cytotoxic preparations; we decided to install a quantitative and qualitative High Performance Liquid Chromatography (HPLC) control of cytotoxic preparations carried inside our pharmacotechnic unit. A 100 μl sample of each preparation was assayed by HPLC with ultraviolet/visible-diode array detection, which enabled the identification of all cytotoxic agents thanks to their characteristic UV spectra. We developed rapid and specific HPLC assays that determined qualitatively and quantitatively the presence of 21 different cytotoxic agents in less than 3.5 min. A fifteen per cent tolerance from the theoretical concentration was chosen in agreement with preparation and dosage bias, and a first period control of more than 4400 preparations revealed that around 7.7% preparations did not conform. The main objective of these controls was to avoid the administration of defective chemotherapies to patients and finally to use their results to identify error factors; as a result we will take corrective measures in order to reduce error frequency.
机译:癌症发病率的不断增长和长期治疗正导致医院药房中越来越多的细胞毒性制剂产生。细胞毒性制剂的安全性和质量标准对于确保治疗效率和限制医源性毒性至关重要。为了确保细胞毒性制剂的过程;我们决定为我们的药房内安装的细胞毒性制剂安装定量和定性的高效液相色谱(HPLC)控制。每种制剂的100μl样品通过HPLC /紫外/可见二极管阵列检测进行测定,这归功于其特征性的UV光谱,因此能够鉴定所有细胞毒性剂。我们开发了快速而专一的HPLC分析方法,可以在不到3.5分钟的时间内定性和定量地确定21种不同细胞毒剂的存在。与制剂和剂量偏差一致,从理论浓度中选择了15%的耐受性,并且第一阶段对4400多种制剂的控制显示,约有7.7%的制剂不合格。这些控制的主要目的是避免对患者进行不良的化学疗法,并最终利用他们的结果来识别错误因素。因此,我们将采取纠正措施以减少错误发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号